about
Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomesUsing alternative statistical formats for presenting risks and risk reductionsEfficacy, quality of life, and acceptability outcomes of atypical antipsychotic augmentation treatment for treatment-resistant depression: protocol for a systematic review and network meta-analysisSelective serotonin reuptake inhibitors versus placebo in patients with major depressive disorder. A systematic review with meta-analysis and Trial Sequential AnalysisThe social and cultural construction of psychiatric knowledge: an analysis of NICE guidelines on depression and ADHD.Placebo, prozac and PLoS: significant lessons for psychopharmacology.Efficacy of antidepressants: a re-analysis and re-interpretation of the Kirsch data.Velusetrag for the treatment of chronic constipation.Comparative efficacy and tolerability of pharmacological and somatic interventions in adult patients with treatment-resistant depression: a systematic review and network meta-analysis.Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis.Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysisNo role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis.Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerabilityCognitive hypnotherapy for major depressive disorder.Improving study design for antidepressant effectiveness assessment.From trial and error to trial simulation. Part 2: an appraisal of current beliefs in the design and analysis of clinical trials for antidepressant drugs.The fallacy of thresholds used in defining response and remission in depression rating scales.Methodological Flaws, Conflicts of Interest, and Scientific Fallacies: Implications for the Evaluation of Antidepressants' Efficacy and Harm.Mapping actions to improve access to medicines for mental disorders in low and middle income countries.Contextualizing Specificity: Specific and Non-Specific Effects of Treatment
P2860
Q21144599-814BBF34-FD7E-4C3C-9630-8741ADC48483Q24235966-57E79B4D-CF33-45D6-A118-4B2056EF54E7Q26828452-8FC166E5-13FD-4281-8038-716C239F4E99Q28736049-682A9657-E3CC-4375-81AA-8036547B8D09Q30428292-B3D816DF-4AEB-42D3-B3D6-54FB23D88623Q33613487-9283B397-7EDB-4FD4-81A0-14582A0411F1Q33676260-E8A366EC-1DC6-4565-9DAF-1FF8F7639E8FQ36042950-1EBBD558-B879-4EFD-A7F8-80D7A804375BQ36236193-63ECB7A4-21FD-464C-A9FF-800FF6ECAD1FQ36588685-225C298B-C20C-49D5-8A4B-087E7DCFA6C0Q36626228-04768011-F96A-4DCB-B20B-355BB34BC831Q37116846-0DAA1C96-3943-4324-811F-BF5158BDD8A8Q37429825-1C748321-5ADE-491A-B7BB-C245A572B741Q38015393-FF9DC290-FF0B-40F4-8DB3-2E85023D4BB2Q38137886-0C9E8689-533E-4226-8912-F1FD9129B613Q43775656-B7F90566-B751-474A-8A1E-6D9AD9F543B7Q45330802-87E00CDD-75A0-45C3-AFCA-FAFF3032DBD9Q47098457-2DD65739-6D2C-4E04-8B45-42805E651555Q47834046-40F982C1-C4A4-47AD-9DFB-D5AF12095B51Q58173214-FC210474-BFDD-4E8C-AE10-3DA2411D4AF9
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Clinical trials and the response rate illusion.
@ast
Clinical trials and the response rate illusion.
@en
Clinical trials and the response rate illusion.
@nl
type
label
Clinical trials and the response rate illusion.
@ast
Clinical trials and the response rate illusion.
@en
Clinical trials and the response rate illusion.
@nl
prefLabel
Clinical trials and the response rate illusion.
@ast
Clinical trials and the response rate illusion.
@en
Clinical trials and the response rate illusion.
@nl
P1476
Clinical trials and the response rate illusion.
@en
P2093
Joanna Moncrieff
P304
P356
10.1016/J.CCT.2006.10.012
P407
P577
2006-12-19T00:00:00Z